- Home
- TELA vs BYSI Comparison
TELA vs BYSI Comparison
Compare TELA & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TELA
- BYSI
- Stock Information
- Founded
- TELA 2012
- BYSI 2010
- Country
- TELA United States
- BYSI United States
- Employees
- TELA N/A
- BYSI N/A
- Industry
- TELA Medical/Dental Instruments
- BYSI Biotechnology: Pharmaceutical Preparations
- Sector
- TELA Health Care
- BYSI Health Care
- Exchange
- TELA Nasdaq
- BYSI Nasdaq
- Market Cap
- TELA 70.1M
- BYSI 80.6M
- IPO Year
- TELA 2019
- BYSI 2017
- Fundamental
- Price
- TELA $1.62
- BYSI $1.90
- Analyst Decision
- TELA Buy
- BYSI
- Analyst Count
- TELA 3
- BYSI 0
- Target Price
- TELA $5.33
- BYSI N/A
- AVG Volume (30 Days)
- TELA 106.3K
- BYSI 26.9K
- Earning Date
- TELA 11-06-2025
- BYSI 08-13-2025
- Dividend Yield
- TELA N/A
- BYSI N/A
- EPS Growth
- TELA N/A
- BYSI N/A
- EPS
- TELA N/A
- BYSI N/A
- Revenue
- TELA $75,323,000.00
- BYSI N/A
- Revenue This Year
- TELA $25.72
- BYSI N/A
- Revenue Next Year
- TELA $22.03
- BYSI N/A
- P/E Ratio
- TELA N/A
- BYSI N/A
- Revenue Growth
- TELA 16.34
- BYSI N/A
- 52 Week Low
- TELA $0.86
- BYSI $0.98
- 52 Week High
- TELA $3.26
- BYSI $3.44
- Technical
- Relative Strength Index (RSI)
- TELA 44.30
- BYSI 50.08
- Support Level
- TELA $1.56
- BYSI $1.67
- Resistance Level
- TELA $1.87
- BYSI $1.84
- Average True Range (ATR)
- TELA 0.16
- BYSI 0.13
- MACD
- TELA -0.01
- BYSI 0.02
- Stochastic Oscillator
- TELA 18.00
- BYSI 65.53
About TELA TELA Bio Inc.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.